• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种实践促进形式对初级保健中心血管预防的影响:一项实践随机、比较有效性试验。

Effects of 2 Forms of Practice Facilitation on Cardiovascular Prevention in Primary Care: A Practice-randomized, Comparative Effectiveness Trial.

机构信息

Department of Medicine, Division of General Internal Medicine and Geriatrics.

Center for Primary Care Innovation.

出版信息

Med Care. 2020 Apr;58(4):344-351. doi: 10.1097/MLR.0000000000001260.

DOI:10.1097/MLR.0000000000001260
PMID:31876643
Abstract

BACKGROUND

Effective quality improvement (QI) strategies are needed for small practices.

OBJECTIVE

The objective of this study was to compare practice facilitation implementing point-of-care (POC) QI strategies alone versus facilitation implementing point-of-care plus population management (POC+PM) strategies on preventive cardiovascular care.

DESIGN

Two arm, practice-randomized, comparative effectiveness study.

PARTICIPANTS

Small and mid-sized primary care practices.

INTERVENTIONS

Practices worked with facilitators on QI for 12 months to implement POC or POC+PM strategies.

MEASURES

Proportion of eligible patients in a practice meeting "ABCS" measures: (Aspirin) Aspirin/antiplatelet therapy for ischemic vascular disease, (Blood pressure) Controlling High Blood Pressure, (Cholesterol) Statin Therapy for the Prevention and Treatment of Cardiovascular Disease, and (Smoking) Tobacco Use: Screening and Cessation Intervention, and the Change Process Capability Questionnaire. Measurements were performed at baseline, 12, and 18 months.

RESULTS

A total of 226 practices were randomized, 179 contributed follow-up data. The mean proportion of patients meeting each performance measure was greater at 12 months compared with baseline: Aspirin 0.04 (95% confidence interval: 0.02-0.06), Blood pressure 0.04 (0.02-0.06), Cholesterol 0.05 (0.03-0.07), Smoking 0.05 (0.02-0.07); P<0.001 for each. Improvements were sustained at 18 months. At 12 months, baseline-adjusted difference-in-differences in proportions for the POC+PM arm versus POC was: Aspirin 0.02 (-0.02 to 0.05), Blood pressure -0.01 (-0.04 to 0.03), Cholesterol 0.03 (0.00-0.07), and Smoking 0.02 (-0.02 to 0.06); P>0.05 for all. Change Process Capability Questionnaire improved slightly, mean change 0.30 (0.09-0.51) but did not significantly differ across arms.

CONCLUSION

Facilitator-led QI promoting population management approaches plus POC improvement strategies was not clearly superior to POC strategies alone.

摘要

背景

需要有效的质量改进(QI)策略来针对小型实践。

目的

本研究的目的是比较单独实施即时护理(POC)QI 策略的实践促进与促进实施即时护理加人群管理(POC+PM)策略在预防心血管护理方面的效果。

设计

双臂、实践随机、比较有效性研究。

参与者

小型和中型初级保健实践。

干预措施

实践与促进者合作,针对 QI 进行为期 12 个月的工作,以实施 POC 或 POC+PM 策略。

测量

实践中符合“ABCS”措施的合格患者比例:(阿司匹林)阿司匹林/抗血小板治疗缺血性血管疾病,(血压)控制高血压,(胆固醇)他汀类药物用于心血管疾病的预防和治疗,以及(吸烟)烟草使用:筛查和戒烟干预,以及变革过程能力问卷。测量在基线、12 个月和 18 个月进行。

结果

共有 226 个实践被随机分配,179 个实践提供了随访数据。与基线相比,12 个月时每个绩效测量的患者比例更高:阿司匹林 0.04(95%置信区间:0.02-0.06),血压 0.04(0.02-0.06),胆固醇 0.05(0.03-0.07),吸烟 0.05(0.02-0.07);每个 P<0.001。18 个月时仍能保持改善。在 12 个月时,POC+PM 臂与 POC 相比的比例差异的调整后差异:阿司匹林 0.02(-0.02 至 0.05),血压-0.01(-0.04 至 0.03),胆固醇 0.03(0.00-0.07),吸烟 0.02(-0.02 至 0.06);所有 P>0.05。变革过程能力问卷略有改善,平均变化 0.30(0.09-0.51),但双臂之间无显著差异。

结论

促进者主导的 QI 促进人群管理方法加上 POC 改进策略并不明显优于单独的 POC 策略。

相似文献

1
Effects of 2 Forms of Practice Facilitation on Cardiovascular Prevention in Primary Care: A Practice-randomized, Comparative Effectiveness Trial.两种实践促进形式对初级保健中心血管预防的影响:一项实践随机、比较有效性试验。
Med Care. 2020 Apr;58(4):344-351. doi: 10.1097/MLR.0000000000001260.
2
Design of healthy hearts in the heartland (H3): A practice-randomized, comparative effectiveness study.健康之心在中心地带的设计(H3):一项实践随机、比较效果研究。
Contemp Clin Trials. 2018 Aug;71:47-54. doi: 10.1016/j.cct.2018.06.004. Epub 2018 Jun 2.
3
Disseminating, implementing, and evaluating patient-centered outcomes to improve cardiovascular care using a stepped-wedge design: healthy hearts for Oklahoma.采用阶梯楔形设计传播、实施和评估以患者为中心的结果以改善心血管护理:俄克拉荷马州的健康心脏计划
BMC Health Serv Res. 2018 Jun 4;18(1):404. doi: 10.1186/s12913-018-3189-4.
4
Differences in Use of Clinical Decision Support Tools and Implementation of Aspirin, Blood Pressure Control, Cholesterol Management, and Smoking Cessation Quality Metrics in Small Practices by Race and Sex.不同种族和性别的小型诊所中临床决策支持工具的使用差异以及阿司匹林、血压控制、胆固醇管理和戒烟质量指标的实施情况。
JAMA Netw Open. 2023 Aug 1;6(8):e2326905. doi: 10.1001/jamanetworkopen.2023.26905.
5
Effective Facilitator Strategies for Supporting Primary Care Practice Change: A Mixed Methods Study.有效促进基层医疗实践变革的策略:一项混合方法研究。
Ann Fam Med. 2022 Sep-Oct;20(5):414-422. doi: 10.1370/afm.2847.
6
Quality of Cardiovascular Disease Care in Small Urban Practices.小型城市医疗机构的心血管疾病护理质量。
Ann Fam Med. 2018 Apr;16(Suppl 1):S21-S28. doi: 10.1370/afm.2174.
7
Does Ownership Make a Difference in Primary Care Practice?所有权对初级医疗实践有影响吗?
J Am Board Fam Med. 2019 May-Jun;32(3):398-407. doi: 10.3122/jabfm.2019.03.180271.
8
Practice Transformation Support and Patient Engagement to Improve Cardiovascular Care: From EvidenceNOW Southwest (ENSW).实践转化支持和患者参与以改善心血管护理:来自 EvidenceNOW 西南(ENSW)。
J Am Board Fam Med. 2020 Sep-Oct;33(5):675-686. doi: 10.3122/jabfm.2020.05.190395.
9
A Randomized Trial of External Practice Support to Improve Cardiovascular Risk Factors in Primary Care.一项随机临床试验:外部实践支持对改善初级保健中心心血管危险因素的作用。
Ann Fam Med. 2019 Aug 12;17(Suppl 1):S40-S49. doi: 10.1370/afm.2407.
10
Readiness and Implementation of Quality Improvement Strategies Among Small- and Medium-Sized Primary Care Practices: an Observational Study.中小型基层医疗实践中质量改进策略的准备情况与实施:一项观察性研究
J Gen Intern Med. 2020 Oct;35(10):2882-2888. doi: 10.1007/s11606-020-05978-w. Epub 2020 Aug 10.

引用本文的文献

1
Improving Early Dementia Detection Among Diverse Older Adults With Cognitive Concerns With the 5-Cog Paradigm: Protocol for a Hybrid Effectiveness-Implementation Clinical Trial.采用5认知范式改善有认知问题的不同老年人群体的早期痴呆症检测:一项混合有效性-实施临床试验方案
JMIR Res Protoc. 2025 Apr 3;14:e60471. doi: 10.2196/60471.
2
Audit and feedback: effects on professional practice.审核与反馈:对专业实践的影响
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD000259. doi: 10.1002/14651858.CD000259.pub4.
3
Quality indicators for the primary prevention of cardiovascular disease in primary care: A systematic review.
基层医疗中心血管疾病一级预防的质量指标:一项系统评价。
PLoS One. 2024 Dec 5;19(12):e0312137. doi: 10.1371/journal.pone.0312137. eCollection 2024.
4
What AHRQ Learned While Working to Transform Primary Care.AHRQ 在努力推动初级保健转型过程中学到了什么。
Ann Fam Med. 2024 Mar-Apr;22(2):161-166. doi: 10.1370/afm.3090.
5
Reducing Care Overuse in Older Patients Using Professional Norms and Accountability : A Cluster Randomized Controlled Trial.利用专业规范和问责制减少老年患者的过度医疗:一项群组随机对照试验。
Ann Intern Med. 2024 Mar;177(3):324-334. doi: 10.7326/M23-2183. Epub 2024 Feb 6.
6
Rationale and design for Healthy Hearts for Michigan (HH4M): A pragmatic single-arm hybrid effectiveness-implementation study.密歇根州健康心脏计划(HH4M)的原理与设计:一项务实的单臂混合有效性-实施研究。
Contemp Clin Trials Commun. 2023 Aug 21;35:101199. doi: 10.1016/j.conctc.2023.101199. eCollection 2023 Oct.
7
Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW.估算初级医疗保健中质量改进计划对降低心血管疾病风险的效果:来自 EvidenceNOW 的研究结果。
J Am Board Fam Med. 2023 May 8;36(3):462-476. doi: 10.3122/jabfm.2022.220331R1. Epub 2023 May 11.
8
A Medicaid Statewide Hypertension Quality Improvement Project: Initial Results.一项医疗补助全州高血压质量改进项目:初步结果
Cureus. 2023 Mar 14;15(3):e36132. doi: 10.7759/cureus.36132. eCollection 2023 Mar.
9
Is more better? The impact of implementing more interventions for hypertension control in a practice facilitation study for small- and medium-sized practices.更多干预措施是否更好?在一项针对中小规模实践的实践促进研究中实施更多高血压控制干预措施的影响。
J Hum Hypertens. 2023 Nov;37(11):1007-1014. doi: 10.1038/s41371-023-00813-1. Epub 2023 Mar 22.
10
Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease.钠-葡萄糖共转运蛋白 2 抑制剂与胰高血糖素样肽-1 受体激动剂在伴或不伴心血管疾病的糖尿病患者中的处方比较。
Am J Cardiol. 2023 Feb 15;189:121-130. doi: 10.1016/j.amjcard.2022.10.041. Epub 2022 Nov 22.